13
Biomedical Signal and Image Computing Laboratory Invariant SPHARM Shape Descriptors for Complex Geometry in MR Region of Interest Analysis Ashish Uthama 1 Rafeef Abugharbieh 1 Anthony Traboulsee 2 Martin J. McKeown 1,2 Presented by Bernard Ng 1 1 Biomedical Signal and Image Computing Laboratory, Department of ECE, University of British Columbia 2 Department of Medicine, University of British Columbia

Invariant SPHARM Shape Descriptors for Complex Geometry in MR Region of Interest Analysis Ashish Uthama 1 Rafeef Abugharbieh 1 Anthony Traboulsee 2 Martin

  • View
    218

  • Download
    0

Embed Size (px)

Citation preview

Biomedical Signal and ImageComputing Laboratory

Invariant SPHARM Shape Descriptors for Complex Geometry in MR Region of Interest Analysis

Ashish Uthama1

Rafeef Abugharbieh1

Anthony Traboulsee2

Martin J. McKeown1,2

Presented by Bernard Ng1

1 Biomedical Signal and Image Computing Laboratory, Department of ECE, University of British Columbia2 Department of Medicine, University of British Columbia

Biomedical Signal and ImageComputing Laboratory

OverviewOverview

Introduction Shape analysis using ROIs in MR Current analysis techniques

Background Our earlier SPHARM approach New SPHARM approach proposed

Method Feature extraction Feature analysis Validation

Results Shape Analysis of the thalamus in PD

Biomedical Signal and ImageComputing Laboratory

Shape Analysis Using ROIs in MRShape Analysis Using ROIs in MR High resolution structural MR helps

in studying deep brain structures

Most neurological disease effect the integrity of brain structures (PD, MS, etc)

In some diseases this effect could be a systematic change in shape

Using ROI (Region of Interest) based shape analysis helps study these changes locally

Introduction Background Method Results 3

Manually traced Region of Interests (ROI) delineating the left and right thalamus for further shape analysis

Biomedical Signal and ImageComputing Laboratory

Current Analysis TechniquesCurrent Analysis Techniques

Voxel count to represent volume Very simplistic measure Does not capture shape

Template based representation (medial, atlas, etc)

Most require manual selection of Land Marks Requires mutual registration

Automated feature extraction Limited to spherical topology

Introduction Background Method Results 4

Biomedical Signal and ImageComputing Laboratory

Our Earlier SPHARM ApproachOur Earlier SPHARM Approach

Scale, rotation and translation invariant

No mutual registration Insensitive to subject (ROI)

orientation or brain size

ROI surface represented as a function of distance from the centre of mass

Thus limited to ROIs without self occlusions

Introduction Background Method Results 5

A limitation for potential future work on arbitrarily complex ROIs (e.g MS leison shape etc)

rF ,

??, F

Cross sections of hypothetical 3D volumes

r

Biomedical Signal and ImageComputing Laboratory

New SPHARM Approach ProposedNew SPHARM Approach Proposed

Based on representing the ROI volume using concentric spherical shells

Arbitrarily shaped ROIs can be analyzed Earlier such representations were not unique

Novel implementation of a radial transform

Ensures unique feature vectors

Introduction Background Method Results 6

Biomedical Signal and ImageComputing Laboratory

Feature Extraction 1Feature Extraction 1

BA

C

A

B C

Determine the maximum radius Rmax (in voxels)

Obtain the bandwidth (L)

Obtain 2Rmax number of shells with radius equally spaced between 1 and Ri,

Intersect these shells with the binary ROI mask, interpolating as required

Introduction Background Method Results 7

max

2max 224

RL

LLR

Biomedical Signal and ImageComputing Laboratory

Feature Extraction 2Feature Extraction 2 Obtain the basic SPHARM

representation for each shell

To obtain unique representation under independent rotations of the ROI section contained in each shell, use a radial transform

Obtain the final invariants

Introduction Background Method Results 8

L

L

L

L

Shell 1 Shell r Shell 2Rmax

… …

cm1l cm

rlcm

2Rmax

l

cm1l

cmrl

cm2R

maxl

.

.

.

.

.

.

Ra

dia

l tran

sform

cm1l

cmkl

cm2R

maxl

.

.

.

.

.

.

drYdc lmmrl sin,,,

2

0 0

*

mrl

R

r

mkl c

r

krrc

sin2

max2

1

2

max2

*,Rk

lk

lm

lm

mkl

mklccqpN

Biomedical Signal and ImageComputing Laboratory

Feature Analysis

Obtain features for both groups (e.g. PD vs. Healthy controls)

Reshape each feature into a vector

Use a permutation test to determine if the two groups have a significant difference

Does not need a generating probability distribution Best suited for long feature vectors seen in biomedical

applications

Introduction Background Method Results 9

Biomedical Signal and ImageComputing Laboratory

Validation Two groups with 20 3D ellipsoidal

volumes each were generated using:

Realistic intersubject variability was introduced by: Random shifts of the centroid Random rotations about all 3 axes Gaussian noise on the surface

With fixed a and b, c was varied over a range to study the performance of the method

Introduction Background Method Results 10

(a) Real data (b) and (c) are the two synthetic groups created

2

2

2

2

2

2

,,ciX

zi

bi

yi

ai

xi

nc

nzcz

nb

nycy

na

nxcxzyx

As the graph approaches cb=10 the group difference in shape reduces

Biomedical Signal and ImageComputing Laboratory

Shape Analysis of the PD Thalami 21 controls and 19 PD patients

were scanned twice. Once before and once two hours after the administration of a drug

Rmax for both thalamus was found to be 20 voxels, 40 shells with a bandwidth of 36 were used

Obtained feature length was 1440

Pre and Post drug analysis yielded no significance

Significant differences observed in both the left and the right thalamus between healthy controls and PD

Introduction Background Method Results 11

Biomedical Signal and ImageComputing Laboratory

Conclusion

SPHARM based invariant feature vectors for a 3D volume

Unique radial transform to obtain unique vectors

Validated with synthetic data

Application to real data Significant shape changes were observed in addition to

volumetric changes indicating that atrophy is not isotropic

Introduction Background Method Results 12

Biomedical Signal and ImageComputing Laboratory

Questions and Comments

[email protected]